Optimising antibiotic policies in the Netherlands. IX. SWAB guidelines for antimicrobial therapy in adults with acute infectious diarrhoea;Optimaliseren van het antibioticabeleid in Nederland. IX. SWAB-richtlijn voor antimicrobiële therapie bij acute infectieuze diarree

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 20, 2006, Pages 1116-1122

  Bos, J C ^a   Schultsz, C ^b,c   Vandenbroucke Grauls, C M J ^a,b   Speelman, P ^a   Prins, J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; CAMPYLOBACTER; DIGESTIVE SYSTEM INFLAMMATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSENTERY; ENVIRONMENTAL DISEASE; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INFECTIOUS DIARRHEA; NETHERLANDS; PRACTICE GUIDELINE; REVIEW; TRAVELLER DIARRHEA; TREATMENT DURATION;

EID: 33745752964     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Wit MA de, Koopmans MP, Kortbeek LM, Wannet WJ, Vinje J, Leusden F van, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol. 2001;154:666-74.
2. Wit MA de, Kortbeek LM, Koopmans MP, Jager CJ de, Wannet WJ, Bartelds AI, et al. A comparison of gastroenteritis in a general practice-based study and a community-based study. Epidemiol Infect. 2001;127:389-97.
3. Gool T van, Weijts R, Lommerse E, Mank TG. Triple faeces test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur J Clin Microbiol Infect Dis. 2003;22:284-90.
4. Hines J, Nachamkin I. Effective use of the clinical microbiology laboratory for diagnosing diarrheal diseases. Clin Infect Dis. 1996;23:1292-301.
5. Johnson S, Gerding DN. Clostridium difficile - associated diarrhea. Clin Infect Dis. 1998;26:1027-34.
6. Wit MA de, Koopmans MP, Kortbeek LM, Leeuwen NJ van, Vinje J, Duynhoven YT van. Etiology of gastroenteritis in sentinel general practices in the Netherlands. Clin Infect Dis. 2001;33:280-8.
7. Black RE. Epidemiology of traveler's diarrhea and relative importance of various pathogens. Rev Infect Dis. 1990;12(Suppl 1):S73-9.
8. Sanders JW, Isenbarger DW, Walz SE, Pang LW, Scott DA, Tamminga C, et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533-8.
9. Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med. 1996;156:1449-54.
10. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336:97-100.
11. Wiström J, Jertborn M, Ekwall E, Norlin K, Soderquist B, Stromberg A, et al. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Ann Intern Med. 1992;117:202-8.
12. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996;22:1019-25.
13. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990;150:541-6.
14. Havelaar HA, redacteur. Campylobacteriose in Nederland. Risico's en interventiemogelijkheden [rapport 250911001]. Bilthoven: RIVM; 2002.
15. Pelt W van, Wannet WJB, Giessen AW van de, Mevius DJ, Duynhoven YTHP van. Trends in gastroenteritis van 1996-2003. Infectieziektenbulletin. 2004;15:335-41.
16. Gordillo ME, Singh KV, Murray BE. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother. 1993;37:1203-5.
17. Jones K, Felmingham D, Ridgway G. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens. Drugs Exp Clin Res. 1988;14:613-5.
18. Kuschner RA, Trofa AF, Thomas RJ, Hoge CW, Pitarangsi C, Amato S, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis. 1995;21:536-41.
19. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med. 1997;126:697-703.
20. Chiu CH, Lin TY, Ou JT. In vitro evaluation of intracellular activity of antibiotics against non-typhoid Salmonella. Int J Antimicrob Agents. 1999;12:47-52.
21. Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother. 1999;43:1441-4.
22. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother. 2000;44:1855-9.
23. Bruyn G de, Hahn S, Borwick A. Antibiotic treatment for traveller's diarrhoea [Cochrane review]. Cochrane Database Syst Rev. 2000;(3):CD002242.
24. Salam I, Katelaris P, Leigh-Smith S, Farthing MJ. Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea. Lancet. 1994:344:1537-9.
25. Petruccelli BP, Murphy GS, Sanchez JL, Walz S, DeFraites R, Gelnett J, et al. Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis. 1992;165:557-60.
26. Isenbarger DW, Hoge CW, Srijan A, Pitarangsi C, Vithayasai N, Bodhidatta L, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis. 2002;8:175-80.
27. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis. 2003;37:1165-71.
28. Taylor DN, Sanchez JL, Candler W, Thornton S, McQueen C, Echeverria P. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med. 1991;114:731-4.
29. Ericsson CD, DuPont HL, Mathewson JJ. Single dose ofloxacin plus loperamide compared with single dose or three days of ofloxacin in the treatment of traveler's diarrhea. J Travel Med. 1997;4:3-7.
30. Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults [Cochrane review]. Cochrane Database Syst Rev. 2005;(1):CD004010.
31. Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986;27:1169-72.
32. Krausz S, Bessems M, Boermeester MA, Kuijper EJ, Visser CE, Speelman P. Levensbedreigende infecties met een nieuwe variant van Clostridium difficile. Ned Tijdschr Geneeskd. 2005;149:2081-6.
33. Olson MM, Shanholtzer CJ, Lee Jr JT, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol. 1994;15:371-81.
34. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile - associated diarrhea: a review. Arch Intern Med. 2001;161:525-33.
35. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334-9.
36. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97:1769-75.